Market
Scenario
The
Global Oral Thrush Market is increasing owing to the rising prevalence of oral
candidiasis and the demand for effective medical care to treat the thrush. Lifestyle has a significant influence on the
physical and mental health of human being. Undoubtedly, today’s unhealthy,
inactive or sedentary lifestyle is the main driving force behind the prevalence
of Candida, further substantiating the market growth.
Furthermore,
various other risk factors for Oral Thrush, such as chronic diseases such as
Cancer, diabetes along with the deadly HIV infection increase chances of
getting infected with dubliniensis and C. geotrichium, increasing patent’s
immunodeficiency. Similarly, smokers
hospitalized patients, and immune-compromised individuals are equally prone to
develop the condition.
Various
factors affects the prevalence of Candida such as high humidity, and
temperature. Females are more prone to develop the condition as compared to
males. Moreover, people wearing dentures, consumption of high carbohydrates
containing diet, suffering from xerostomia (dry mouth) are at a higher risk of
developing oral thrush. Other factors affecting the market for oral thrush is
age with newborns and aged population having the least prevalence while infants
having the highest.
Market
development represents the best strategy for the market growth. The market will
witness exponential growth over the review period owing to advanced
antibacterial mouth rinses and improving palatability and quality of oral
hygiene products. The developing regions of Asia and the Middle East are
attracting new players owing to less regional competition for the oral thrush
product. Increase in risk factors such as high fat containing and sugar rich
foods, growing screening, increasing infant population. On the other hand, the
market may experience a slow growth on account of lack of awareness and
misdiagnosis of the disease.
The
global oral thrush market is expected to reach USD 9.5 billion by 2023, and the
market is projected to grow at a CAGR of ~ 4.4 % during the forecast period
2017-2023.
Segments:
The global oral thrush market has been segmented on the basis of type, diagnosis, treatment, and end user.
The global oral thrush market has been segmented on the basis of type, diagnosis, treatment, and end user.
Based on
type, the market has been segmented as pseudomembranous, erythematous,
hyperplastic, and others.
Based on
diagnosis, the market has been segmented as examination, biopsy, endoscopy, and
others.
Based on
treatment, the market has been segmented as anti-fungal, immune-modulators, and
others.
Based on
the end user, the market has been segmented as hospitals & clinics,
academic and research, and others.
Regional
Analysis
Globally,
the North America market dominates the Oral Thrush market. Factors such as the
well-spread awareness among people towards the oral hygiene and healthcare
along with the extensive use of medications and high expenditure on the health
care and augmenting uptake of new products primarily in the US drive the market
growth in the region.
Simultaneously,
the presence of the leading global players in the region is some of the key
factor substantiating the growth of the regional market. Witnessing a widening
uptake of oral hygiene products across the region, the North America market for
Oral Thrush is likely to continue its dominance throughout the assessment
period. The North American market
significantly contributing to the GDP is expected to register a significant
CAGR during the forecast period.
The
Europe market accounts for the second-largest market for Oral Thrush owing to
the proliferation of healthcare sector, the presence of well-established
players and growing healthcare expenditures in the region. Indeed, the
resurging economy is the main driving force increasing the market value in the
region.
The
Europe healthcare industry is currently booming given the increasing number of
medical professionals and growing awareness in the region. Moreover, the high
influence of media and the rise in the awareness regarding oral hygiene
especially in the countries such as Germany and France drive the European oral
thrush market.
The Asia
Pacific Oral Thrush market emerging as the fastest growing market accounts for
a substantial market share on the global platform. Factors such as the
proliferation of healthcare sector in populous countries such as India and
China substantiate the market growth in the region.
Furthermore,
factors such as augmenting demand for high standards and high-quality oral care
products along with the growing technological advancement are estimated to
increase the market scope, boosting the demand for effective oral care treatments
in the region.
Key Players in the Global Oral Thrush Market
Key Players in the Global Oral Thrush Market
Some of
key players profiled in the report are Bayer AG, Teva Pharmaceuticals,
Stellar Pharma, Pfizer Inc., Wockhardt Ltd., Ranbaxy Laboratories Limited,
Bristol Laboratories, Glenmark Pharmaceuticals, GlaxoSmithKline Plc., and
others.
Browse Complete 85
Pages Premium Research Report Enabled with Respective Tables and Figures @ https://www.marketresearchfuture.com/reports/oral-thrush-market-4417
Detailed Table
of Contents:
1. Report Prologue
2. Introduction
2.1 Definition
2.2 Scope Of The Study
2.2.1 Research Objective
2.2.2 Assumptions
2.2.3 Limitations
2.3 Market Structure
2.4. Market Segmentation
3. Research Methodology
3.1 Research Process
3.2 Primary Research
3.3 Secondary Research
3.4 Market Size Estimation
3.5 Forecast Model
...Continued
About US:
Market Research
Future (MRFR), enable customers to unravel the complexity of various industries
through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw
Research Reports (3R), Continuous-Feed Research (CFR), and Market Research
& Consulting Services.
Contact Us:
Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune - 411028
Maharashtra, India
Phone: +1 646 845 9312
Email: sales@marketresearchfuture.com
No comments:
Post a Comment